Wangyuhl Oh

Title: Innovations of Wangyuhl Oh

Introduction

Wangyuhl Oh is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of three patents to his name, his work focuses on addressing diseases associated with abnormal blood vessels.

Latest Patents

Wangyuhl Oh's latest patents include innovative anti-angiopoietin-2 antibodies that induce Tie2 activation. These mouse antibodies bind to angiopoietin-2 (Ang2) and are humanized for therapeutic use. The anti-Ang2 antibodies serve a dual purpose by activating the Tie2 receptor while neutralizing Ang2. This unique property allows them to normalize abnormal and pathological blood vessels, demonstrating therapeutic efficacy against various diseases and disorders linked to these conditions. Furthermore, his invention includes an angiogenesis inhibitor and a composition for treating diseases associated with abnormal Ang2 expression and Tie2 dysregulation.

Career Highlights

Wangyuhl Oh has worked at notable institutions such as the Korea Advanced Institute of Science and Technology and the Institute for Basic Science. His research has significantly advanced the understanding of angiogenesis and its implications in various medical conditions.

Collaborations

Wangyuhl Oh has collaborated with esteemed colleagues, including Jang Ryul Park and Gou Young Koh. Their combined expertise has contributed to the success of his innovative projects.

Conclusion

Wangyuhl Oh's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in therapeutic treatments for diseases related to blood vessel abnormalities.